Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Pricing Sign in

Telix Pharmaceuticals Limited TLX

Full chart Compare
Set alert

Price alert · TLX

All alert types
9.55 USD -0.34 (-3.44%)

Nov 10, 2026, 10:04 AM EST

9.49 Day range 9.57
6.28 52-week range 13.11
YTD
+27.50%
1 year
-5.26%

Revenue & Expenses

Other Income → Expenses: $5.83MExpenses → Selling, General & Admin: $192.56MExpenses → Research & Development: $171.25MExpenses → Other Operating Expenses: $32.86MExpenses → Interest Expense: $40.87MExpenses → Income Tax: $1.86MGross Profit → Expenses: $426.44MRevenue → Gross Profit: $426.44MRevenue → Cost of Revenue: $377.36MNet Loss → Expenses: $7.13MOther Income$5.83MGross Profit$426.44MNet Loss$7.13MCost of Revenue$377.36MExpenses$439.39MSelling, General & Admin$192.56MResearch & Development$171.25MOther Operating Expenses$32.86MInterest Expense$40.87MIncome Tax$1.86MRevenue$803.79M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Income statement

Full income statement How to read it
TLX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022
803.79M516.55M332.98M160.10M
426.44M336.16M209.53M94.93M
29.78M55.18M11.01M-91.93M
-7.13M33.69M4.21M-104.08M

Balance sheet

Full balance sheet How to read it
TLX annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022
141.87M440.00M84.30M116.33M
1.16B940.38M277.26M255.35M
748.61M587.44M174.61M175.35M
467.11M360.16M12.26M10.45M
415.38M352.94M102.64M80.01M

Cash flow

Full cash flow How to read it
TLX annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022
-17.29M27.49M14.27M-63.97M
-285.92M-86.69M-16.84M-17.00M
-3.72M416.79M7.09M174.96M
-25.69M-9.12M-6.31M-7.04M
-306.93M357.59M4.53M93.99M